Replies to post #90191 on Biotech Values

[DewDiligence]

VRTX:

I got the sense there may possibly be a shorter duration arm that would be followed by the 12 week.

I do not understand what you mean—please clarify.

[ghmm]

VRTX:

Just to add 2 more things from the call.

Trial would be naive and would have two other arms Telaprevir+SOC and 222+SOC.
I couldn't quite understand the speaker in the 36-37 minute mark if I heard correctly I think he said something about ramping up to 12 weeks of treatment.

[DewDiligence]

Re: Telaprevir + VX-222

I doubt that the phase-2 trial will have an SoC-only arm.